FI943421L - 1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä - Google Patents

1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä Download PDF

Info

Publication number: FI943421L
Authority: FI; Finland
Prior art keywords: medicine; benzodiazepine derivatives; benzodiazepine; derivatives
Prior art date: 1992-01-21

Application number

FI943421A

Other languages

English (en)

Swedish (sv)

Other versions

FI111632B (fi

FI943421A0 (fi

Inventor

Harry Finch

David Gordon Trist

Giorgio Tarzia

Aldo Feriani

Original Assignee

Glaxo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-01-21

Filing date

1994-07-19

Publication date

1994-07-19

1994-07-19 Application filed by Glaxo Spa filed Critical Glaxo Spa

1994-07-19 Publication of FI943421L publication Critical patent/FI943421L/fi

1994-07-19 Publication of FI943421A0 publication Critical patent/FI943421A0/fi

2003-08-29 Application granted granted Critical

2003-08-29 Publication of FI111632B publication Critical patent/FI111632B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FI943421A 1992-01-21 1994-07-19 Menetelmä CCK-B-antagonistisesti vaikuttavien 1,5-bentsodiatsepiinijohdannaisten valmistamiseksi FI111632B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB9201180		1992-01-21
GB929201180A GB9201180D0 (en)	1992-01-21	1992-01-21	Chemical compounds
PCT/EP1993/000098 WO1993014074A1 (en)	1992-01-21	1993-01-19	1,5-benzodiazepine derivatives and their use in medicine
EP9300098		1993-01-19

Publications (3)

Publication Number	Publication Date
FI943421L true FI943421L (fi)	1994-07-19
FI943421A0 FI943421A0 (fi)	1994-07-19
FI111632B FI111632B (fi)	2003-08-29

Family

ID=10708914

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI943421A FI111632B (fi)	1992-01-21	1994-07-19	Menetelmä CCK-B-antagonistisesti vaikuttavien 1,5-bentsodiatsepiinijohdannaisten valmistamiseksi

Country Status (29)

Country	Link
US (2)	US5580895A (fi)
JP (1)	JP3253723B2 (fi)
KR (1)	KR100263625B1 (fi)
CN (1)	CN1049217C (fi)
AP (1)	AP369A (fi)
AU (2)	AU3450193A (fi)
BG (1)	BG61876B1 (fi)
CA (1)	CA2087672C (fi)
CZ (1)	CZ283950B6 (fi)
FI (1)	FI111632B (fi)
GB (1)	GB9201180D0 (fi)
GE (1)	GEP20001968B (fi)
HU (2)	HU221297B1 (fi)
IL (1)	IL104447A (fi)
IS (1)	IS3970A (fi)
MX (1)	MX9300261A (fi)
MY (1)	MY131307A (fi)
NO (1)	NO305952B1 (fi)
NZ (1)	NZ245715A (fi)
OA (1)	OA09964A (fi)
PH (1)	PH30894A (fi)
PL (1)	PL175340B1 (fi)
RO (1)	RO114128B1 (fi)
RU (1)	RU2124009C1 (fi)
SK (1)	SK280173B6 (fi)
TW (1)	TW226013B (fi)
UA (1)	UA29416C2 (fi)
WO (1)	WO1993014074A1 (fi)
ZA (1)	ZA93375B (fi)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9225492D0 (en) *	1992-12-05	1993-01-27	Glaxo Group Ltd	Amine derivatives
WO1994024151A1 (en) *	1993-04-15	1994-10-27	Glaxo Inc.	1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity
GB9307833D0 (en) *	1993-04-15	1993-06-02	Glaxo Inc	Modulators of cholecystokinin and gastrin
GB9308431D0 (en) *	1993-04-23	1993-06-09	Glaxo Spa	Chemical compounds
GB9308421D0 (en) *	1993-04-23	1993-06-09	Glaxo Spa	Chemical compounds
GB2280182A (en) *	1993-07-20	1995-01-25	Glaxo Spa	Benzodiazepine derivatives
GB9314977D0 (en) *	1993-07-20	1993-09-01	Glaxo Spa	Chemical compounds
GB9314981D0 (en) *	1993-07-20	1993-09-01	Glaxo Spa	Chemical compounds
GB9315018D0 (en) *	1993-07-20	1993-09-01	Glaxo Spa	Chemical compounds
US5739129A (en) *	1994-04-14	1998-04-14	Glaxo Wellcome Inc.	CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
JPH09511223A (ja) *	1994-04-14	1997-11-11	グラクソ、ウェルカム、インコーポレーテッド	Ｃｃｋまたはガストリンを調節する５−ヘテロシクロ−１，５−ベンゾジアゼピン
PE27497A1 (es) *	1994-04-15	1997-08-07	Glaxo Inc	Derivados de 1,5 benzodiazepina
GB9420748D0 (en) *	1994-10-14	1994-11-30	Glaxo Inc	1,5 benzodiazepine derivatives
US5780464A (en) *	1994-10-14	1998-07-14	Glaxo Wellcome Inc.	Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
CA2239293A1 (en)	1995-12-11	1997-06-19	New England Medical Center Hosptials, Inc.	Assay for and uses of peptide hormone receptor ligands
US5750353A (en) *	1995-12-11	1998-05-12	New England Medical Center Hospitals, Inc.	Assay for non-peptide agonists to peptide hormone receptors
DE69724644T4 (de) *	1996-12-10	2006-08-10	Zeria Pharmaceutical Co., Ltd.	1,5-benzodiazepin-derivate
RU2321583C2 (ru) *	2001-01-22	2008-04-10	Мемори Фармасьютиклз Корпорейшн	Применение производных анилина в качестве ингибиторов фосфодиэстеразы 4
JP4613157B2 (ja) *	2003-01-14	2011-01-12	サイトキネティクス・インコーポレーテッド	化合物、組成物および方法
GB0307918D0 (en) *	2003-04-05	2003-05-14	Astrazeneca Ab	Therapeutic use
RU2377987C2 (ru) *	2003-11-18	2010-01-10	Бёрингер Ингельхайм Интернациональ Гмбх	Твердая лекарственная форма
PL216049B1 (pl)	2004-06-17	2014-02-28	Cytokinetics Inc	Pochodne mocznika, kompozycje zawierajace pochodne mocznika oraz zastosowanie pochodnych mocznika do wytwarzania leku do leczenia niewydolnosci serca
US7538223B2 (en)	2005-08-04	2009-05-26	Cytokinetics, Inc.	Compounds, compositions and methods
US7825120B2 (en)	2005-12-15	2010-11-02	Cytokinetics, Inc.	Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
US20070161617A1 (en)	2005-12-15	2007-07-12	Morgan Bradley P	Certain chemical entities, compositions and methods
WO2007078815A2 (en)	2005-12-16	2007-07-12	Cytokinetics, Inc.	Certain chemical entities, compositions, and methods
JP5178526B2 (ja)	2005-12-19	2013-04-10	サイトキネティクス・インコーポレーテッド	化合物、組成物および方法
CU20090172A6 (es)	2009-10-09	2011-10-05	Facultad De Quimica Universidad De La Habana	Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
JP6014904B2 (ja)	2011-07-29	2016-10-26	国立大学法人徳島大学	Ｅｒａｐ１由来ペプチド及びその使用
CN103435562B (zh) *	2013-08-26	2016-02-24	华东理工大学	6-取代苯并二氮卓-2,4-二酮类化合物及其用途
CN108200760B (zh)	2015-07-22	2022-04-01	英安塔制药有限公司	作为rsv抑制剂的苯并二氮杂䓬衍生物
EP3402799B1 (en)	2016-01-15	2022-05-04	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as rsv inhibitors
ES2923521T3 (es)	2017-02-16	2022-09-28	Enanta Pharm Inc	Procesos para la preparación de derivados de benzodiazepina
WO2018226801A1 (en) *	2017-06-07	2018-12-13	Enanta Pharmaceuticals, Inc.	Aryldiazepine derivatives as rsv inhibitors
US11091501B2 (en)	2017-06-30	2021-08-17	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as RSV inhibitors
WO2019006291A1 (en)	2017-06-30	2019-01-03	Enanta Pharmaceuticals, Inc.	HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
JP7198811B2 (ja)	2017-09-29	2023-01-04	エナンタファーマシューティカルズインコーポレイテッド	Ｒｓｖ阻害剤としての組み合わせ医薬剤
WO2019094920A1 (en)	2017-11-13	2019-05-16	Enanta Pharmaceuticals, Inc.	Azepin-2-one derivatives as rsv inhibitors
WO2019199908A1 (en)	2018-04-11	2019-10-17	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as rsv inhibitors
US20220098256A1 (en)	2018-11-30	2022-03-31	Tokushima University	Therapeutic agent for breast cancer comprising big3-phb2 interaction-inhibiting peptide derived from phb2
CN113710276B (zh)	2019-03-18	2024-03-29	英安塔制药有限公司	苯二氮䓬衍生物作为rsv抑制剂
US11179400B2 (en)	2019-04-09	2021-11-23	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as RSV inhibitors
US11505558B1 (en)	2019-10-04	2022-11-22	Enanta Pharmaceuticals, Inc.	Antiviral heterocyclic compounds
UY39032A (es)	2020-01-24	2021-07-30	Enanta Pharm Inc	Compuestos heterocíclicos como agentes antivirales
WO2022010882A1 (en)	2020-07-07	2022-01-13	Enanta Pharmaceuticals, Inc,	Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
US11945824B2 (en)	2020-10-19	2024-04-02	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as anti-viral agents
AR129003A1 (es)	2022-04-07	2024-07-03	Enanta Pharm Inc	Compuestos heterocíclicos antivirales
US12162857B2 (en)	2022-04-27	2024-12-10	Enanta Pharmaceuticals, Inc.	Antiviral compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3984398A (en) *	1966-12-14	1976-10-05	Roussel-Uclaf	1,5-Benzodiazepine-2,4-diones
US4207228A (en) *	1977-09-21	1980-06-10	The B. F. Goodrich Company	UV-Light-stabilized compositions containing substituted 1,5-diazacycloalkanes, novel compounds and synthesis thereof
JPS60158190A (ja) *	1984-01-30	1985-08-19	Eisai Co Ltd	ヒダントイン誘導体およびその製法ならびにそれを含有する医薬
US4647561A (en) *	1985-08-05	1987-03-03	E. R. Squibb & Sons, Inc.	1,5-benzodiazepine compounds
FR2641280B1 (fr) *	1988-12-29	1994-01-21	Roussel Uclaf	Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments

1992
- 1992-01-21 GB GB929201180A patent/GB9201180D0/en active Pending
- 1992-01-21 GE GEAP19922651A patent/GEP20001968B/en unknown
1993
- 1993-01-15 US US08/256,359 patent/US5580895A/en not_active Expired - Fee Related
- 1993-01-19 RO RO94-01216A patent/RO114128B1/ro unknown
- 1993-01-19 KR KR1019940702491A patent/KR100263625B1/ko not_active Expired - Fee Related
- 1993-01-19 RU RU94037768A patent/RU2124009C1/ru active
- 1993-01-19 PL PL93304684A patent/PL175340B1/pl unknown
- 1993-01-19 SK SK864-94A patent/SK280173B6/sk unknown
- 1993-01-19 HU HU9402150A patent/HU221297B1/hu not_active IP Right Cessation
- 1993-01-19 UA UA94005364A patent/UA29416C2/uk unknown
- 1993-01-19 WO PCT/EP1993/000098 patent/WO1993014074A1/en not_active Ceased
- 1993-01-19 AU AU34501/93A patent/AU3450193A/en not_active Abandoned
- 1993-01-19 CZ CZ941736A patent/CZ283950B6/cs not_active IP Right Cessation
- 1993-01-20 NZ NZ245715A patent/NZ245715A/en unknown
- 1993-01-20 CA CA002087672A patent/CA2087672C/en not_active Expired - Fee Related
- 1993-01-20 AP APAP/P/1993/000478A patent/AP369A/en active
- 1993-01-20 PH PH45583A patent/PH30894A/en unknown
- 1993-01-20 IS IS3970A patent/IS3970A/is unknown
- 1993-01-20 IL IL104447A patent/IL104447A/en not_active IP Right Cessation
- 1993-01-20 JP JP02483193A patent/JP3253723B2/ja not_active Expired - Fee Related
- 1993-01-20 AU AU31935/93A patent/AU661749B2/en not_active Ceased
- 1993-01-20 MY MYPI93000093A patent/MY131307A/en unknown
- 1993-01-20 MX MX9300261A patent/MX9300261A/es not_active IP Right Cessation
- 1993-01-20 ZA ZA93375A patent/ZA93375B/xx unknown
- 1993-01-21 CN CN93101143A patent/CN1049217C/zh not_active Expired - Fee Related
- 1993-02-02 TW TW082100666A patent/TW226013B/zh active
1994
- 1994-06-27 BG BG98881A patent/BG61876B1/bg unknown
- 1994-07-18 OA OA60539A patent/OA09964A/en unknown
- 1994-07-19 FI FI943421A patent/FI111632B/fi active
- 1994-07-20 NO NO942720A patent/NO305952B1/no unknown
1995
- 1995-06-16 HU HU95P/P00242P patent/HU211295A9/hu unknown
1996
- 1996-07-01 US US08/674,259 patent/US5637697A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BG61876B1 (bg)	1998-08-31
OA09964A (en)	1995-12-11
WO1993014074A1 (en)	1993-07-22
CA2087672C (en)	2003-08-05
MY131307A (en)	2007-08-30
RO114128B1 (ro)	1999-01-29
HU9402150D0 (en)	1994-09-28
GEP20001968B (en)	2000-03-05
IS3970A (is)	1993-07-22
CN1049217C (zh)	2000-02-09
FI111632B (fi)	2003-08-29
IL104447A0 (en)	1993-05-13
US5637697A (en)	1997-06-10
MX9300261A (es)	1994-03-31
AU3193593A (en)	1993-07-22
AP9300478A0 (en)	1993-01-31
BG98881A (bg)	1995-03-31
HUT67375A (en)	1995-03-28
AU661749B2 (en)	1995-08-03
NO942720L (no)	1994-07-20
SK280173B6 (sk)	1999-09-10
HU221297B1 (en)	2002-09-28
RU94037768A (ru)	1996-08-10
IL104447A (en)	1998-02-22
HU211295A9 (en)	1995-11-28
ZA93375B (en)	1994-07-18
NZ245715A (en)	1995-07-26
PL175340B1 (pl)	1998-12-31
AP369A (en)	1994-11-06
PH30894A (en)	1997-12-23
TW226013B (fi)	1994-07-01
SK86494A3 (en)	1995-03-08
JPH07118244A (ja)	1995-05-09
CZ173694A3 (en)	1995-09-13
JP3253723B2 (ja)	2002-02-04
CZ283950B6 (cs)	1998-07-15
NO942720D0 (no)	1994-07-20
RU2124009C1 (ru)	1998-12-27
KR100263625B1 (ko)	2000-11-01
CN1074678A (zh)	1993-07-28
FI943421A0 (fi)	1994-07-19
GB9201180D0 (en)	1992-03-11
CA2087672A1 (en)	1993-07-22
NO305952B1 (no)	1999-08-23
UA29416C2 (uk)	2000-11-15
US5580895A (en)	1996-12-03
AU3450193A (en)	1993-08-03

Publication	Publication Date	Title
FI943421L (fi)	1994-07-19	1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä
FI952179A7 (fi)	1995-05-05	Uusia 3,3-difenyylipropyyliamiineja, niiden käyttö ja valmistus
FI953479A7 (fi)	1996-01-20	1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI20000516A7 (fi)	2000-03-07	Bis-indolyylimaleimidijohdannaiset ja niiden valmistus
FI945281A7 (fi)	1995-05-11	Heterosykliset yhdisteet, niiden valmistus ja käyttö
FI961599A7 (fi)	1996-06-07	1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
FI945625A7 (fi)	1994-11-29	Indolokarbatsoli-imidit ja niiden käyttö
FI923775A7 (fi)	1993-02-24	2-piperatsinoniyhdisteet, niiden valmistus ja käyttö
FI990387A7 (fi)	1999-02-23	Tienopyrimidiinijohdannaiset, niiden valmistus ja käytt"
FI952709A7 (fi)	1995-08-01	1,4-bentsodiatsepiinijohdannaisia ja niiden käyttö cck-modulaattoreina
FI935887L (fi)	1994-06-29	Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö
FI943313L (fi)	1994-07-12	Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI964482L (fi)	1996-11-07	Amidijohdannaisia ja niiden käyttö lääkkeenä
FI910300A7 (fi)	1991-07-23	Uusia 1,3-dikarbonyyliyhdisteitä ja niiden käyttö
FI953021L (fi)	1995-06-19	4-bentsoyyli-isoksatsolin johdannaisia ja niiden käyttö herbisideinä
FI930716A7 (fi)	1993-08-21	Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
FI954229L (fi)	1995-09-08	Heterosykliset yhdisteet, niiden käyttö ja valmistus
FI934221A7 (fi)	1994-03-29	Piperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI923458A7 (fi)	1992-07-31	4,5-sykloalkano-3-bentsatsepin-7-olijohdannaiset ja niiden käyttö
FI941958A7 (fi)	1994-04-28	2-heterosyklinenetyyliamiinijohdannaiset ja niiden käyttö lääkkeinä
FI930238A7 (fi)	1993-07-23	N-5-suojatut 2,5-diamino-4,6-diklooripyrimidiinit ja menetelmä niiden valmistamiseksi
ZA913171B (en)	1992-02-26	1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use
FI955142L (fi)	1995-10-27	Bentso(f)kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeinä
FI895370A7 (fi)	1990-05-15	1-aminoalkyyli-3-oksisubstituoitu-4-aryyli-1,3,4,5-tetra-hydro-2H-1,3-bentsodiatsepin-2-oneja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI933468A7 (fi)	1994-02-06	Tetrahydronaftaleenijohdannaiset, niiden valmistus ja niiden terapeuttinen käyttö